BNVIF.US Binovi Technologies Corp
- Market cap
- USD 13.3K
- P/E
- -
- P/B
- 0.08x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 4 quarters up to May 2023.
Is BNVIF.US undervalued?
Graham numberThe Graham number of Binovi Technologies Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Binovi Technologies Corp fundamental analysis
No fundamental analysis for Binovi Technologies Corp yet.
Binovi Technologies Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Binovi Technologies Corp
Binovi Technologies Corp. engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. The company's products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regi…
Full company profileBinovi Technologies Corp financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 4 quarters up to May 31, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Binovi Technologies Corp annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | - | 67.6K | 97.0K | 98.9K | 667K | 687K | 728K | 186K | - |
| Gross Profit | - | - | - | 60.1K | 76.2K | 85.5K | 376K | 585K | 523K | 132K | - |
| Operating Income | -153K | -528K | -865K | -3.71M | -4.32M | -2.68M | -4.44M | -7.61M | -6.77M | -5.24M | - |
| EBITDA | -153K | -528K | -838K | -3.60M | -4.17M | -2.55M | -4.60M | -7.46M | -8.32M | -15.1M | - |
| Net Income | -146K | -701K | -866K | -3.84M | -4.34M | -2.71M | -4.77M | -7.69M | -9.14M | -16.4M | - |
| EPS | -1.13 | -4.88 | -5.13 | -8.56 | -7.87 | -4.07 | -4.76 | -4.23 | -1.09 | -0.90 | - |
| Balance Sheet | |||||||||||
| Total Assets | 582K | 274K | 175K | 2.60M | 2.27M | 1.68M | 4.90M | 3.47M | 12.3M | 1.08M | - |
| Total Liabilities | 21.4K | 115K | 441K | 321K | 304K | 560K | 1.20M | 2.08M | 2.42M | 3.41M | - |
| Shareholders' Equity | 560K | 159K | -266K | 2.28M | 1.96M | 1.12M | 3.70M | 1.39M | 9.88M | -2.32M | - |
| Cash & Short-term Investments | 368K | 64.2K | 7.77K | 567K | 570K | 181K | 2.16M | 231K | 117K | 848K | - |
| Total Debt | - | - | - | - | - | - | - | 107K | 74.0K | 897K | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -109K | -442K | -555K | -4.19M | -2.87M | -2.20M | -4.75M | -6.53M | -6.07M | -2.17M | - |
| Capital Expenditure | 42.9K | 7.93K | 0.00 | 322K | 7.63K | 7.63K | 16.9K | 16.9K | 0.00 | 0.00 | - |
| Free Cash Flow | -151K | -449K | -555K | -4.52M | -2.87M | -2.20M | -4.75M | -6.54M | -6.07M | -2.17M | - |
| Ratios | |||||||||||
| ROE | -26.1% | -440.3% | - | -168.9% | -220.8% | -242.2% | -129.1% | -554.4% | -92.6% | - | - |
| ROA | -25.1% | -255.5% | -494.9% | -148.0% | -191.2% | -161.5% | -97.4% | -221.6% | -74.4% | -1,511.1% | - |
| Net Profit Margin | - | - | - | -5,683.3% | -4,468.9% | -2,743.4% | -715.9% | -1,118.9% | -1,255.3% | -8,790.2% | - |
| Debt to Equity | - | - | - | - | - | - | - | 0.08x | 0.01x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Binovi Technologies Corp dividends
Binovi Technologies Corp has not paid dividends in the last 10 fiscal years.
Last stock split: 1:10 on Oct 21, 2021.
Who owns Binovi Technologies Corp
- Insiders 5.94%
- Institutions 0.00%
- Public & others 94.06%
- Shares outstanding 26.6M
- Free float 25.0M
Binovi Technologies Corp company profile
- Company name
- Binovi Technologies Corp
- Ticker
- BNVIF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Fiscal year end
- February
- Address
- 574 Chartwell Rd, Oakville, ON, Canada, L6J 4A5
- Phone
- 844 866 6162
- Website
- binovi.com
About Binovi Technologies Corp
Binovi Technologies Corp. engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. The company's products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub. The company's products under development includes Binovi Connect, a web-based video conferencing solution that connects consumers to vision care professionals. Binovi Technologies Corp. was formerly known as Eyecarrot Innovations Corp. and changed its name to Binovi Technologies Corp. in June 2020. The company was incorporated in 2011 and is based in Oakville, Canada.
Binovi Technologies Corp management
4- Mr. Adam R. Cegielski B.ScFounder & Advisor · born 1976
- Mr. Jatinder DhaliwalCEO, Interim CFO & Director · born 1988
- Mr. Joe LiaDirector of Video Production & Member of Advisory Board
- Dr. Robert SanetSpecial Advisor of Behavioral Optometry & Vision Training